1800 202 8726
Liquid biopsy & newer methods

When Is a Liquid Biopsy — Genuinely Useful?

A liquid biopsy sounds like it could replace a painful needle procedure entirely. In certain situations it can. In others it cannot, and knowing the difference before you ask for one saves time, money, and false reassurance.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed September 2026

  • Not a first-diagnosis tool — A blood test alone cannot confirm cancer is present. Tissue remains the standard of care.
  • Strongest for resistance testing — When treatment stops working, a liquid biopsy can detect the new mutation driving resistance without another biopsy procedure.
  • Useful for monitoring — Falling levels of tumour DNA in the blood can indicate a treatment is working.
  • A negative result is not a clear signal — Not detecting tumour DNA does not mean cancer is absent — it may mean not enough is circulating to find.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Liquid biopsy is most useful when cancer treatment has stopped working and a new resistance mutation may have appeared. It is also used to monitor how well treatment is working over time. It cannot replace a tissue biopsy for a first diagnosis or for confirming cancer is present.

Liquid biopsy or tissue biopsy: which situation calls for which?

SituationTissue biopsyLiquid biopsy
Making a first cancer diagnosisRequired — the standard of careCannot replace tissue; not recommended alone
Detecting resistance when treatment stops workingOften difficult or impossible to repeatWell-supported: can detect new mutations in circulating tumour DNA
Monitoring response during treatmentNot practical to repeat frequentlyUseful: declining tumour DNA levels can indicate response
First treatment choice when tissue sample is limitedPreferred when sufficient tissue is availableA recognised complement when the original sample is insufficient
Detecting minimal residual disease after surgeryNot practicalBeing evaluated — not yet standard practice for most cancers

Why resistance testing is where a blood test genuinely earns its place

When a targeted therapy stops working, the reason is almost always a new mutation that the original drug can no longer overcome. Finding that mutation used to mean another invasive biopsy — often of a site that was difficult or risky to reach.

A liquid biopsy analyses circulating tumour DNA shed by cancer cells into the bloodstream. When a resistance mutation appears there, your oncologist can see which one it is and consider whether a different targeted drug addresses it — without a new needle procedure.

NCCN and ESMO both recognise liquid biopsy as a clinically valid option for resistance testing in several cancers, particularly lung cancer with EGFR mutations. Your oncologist will tell you whether your cancer type and treatment history make it the right next step for you.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

Words your team may use

Liquid biopsy
A blood test that looks for tumour material — fragments of DNA or cells — circulating in the bloodstream. It is not a biopsy in the surgical sense; no tissue is removed.
ctDNA (circulating tumour DNA)
Fragments of DNA released specifically by cancer cells into the blood. The test analyses these fragments for mutations rather than examining a piece of tissue directly.
cfDNA (cell-free DNA)
All the DNA fragments floating in blood, from cancer cells and normal cells alike. ctDNA is the fraction that comes specifically from tumour cells — often a very small proportion.
Resistance mutation
A new change in a cancer cell's DNA that allows it to keep growing despite a drug that was working before. Identifying which mutation has appeared tells your oncologist which alternative to consider.
Minimal residual disease (MRD)
A very small amount of cancer remaining after treatment — too little to show on a scan. Liquid biopsy is being studied as a way to detect MRD, but this is investigational for most cancers.

What a blood test still cannot tell you

It cannot confirm cancer is present. If your doctor suspects cancer for the first time, a tissue biopsy is the only way to make a diagnosis. A negative liquid biopsy does not mean cancer is absent — it may mean not enough tumour DNA is circulating to be detected.

It cannot stage the disease or identify what type of cells are involved. Surgery decisions, radiation planning, and most first treatment choices still require tissue.

A liquid biopsy result should always be interpreted by your oncologist alongside your scans, your symptoms, and your full history. It is one piece of information, not a verdict on its own.

Explore 62 more Biopsy Techniques and How They Compare topics

All Biopsy Techniques and How They Compare →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Can a liquid biopsy replace a tissue biopsy entirely?

Not at this stage. Tissue biopsy remains the standard for a first cancer diagnosis, for staging, and for most decisions about starting treatment. Liquid biopsy earns its place in specific situations — particularly when a targeted therapy has stopped working and your oncologist needs to identify which resistance mutation has appeared, or when reaching the tumour for a repeat biopsy is too difficult or risky. A negative liquid biopsy does not mean cancer is absent; it means the test did not detect enough circulating tumour DNA to find what it was looking for.

When would my oncologist actually order a liquid biopsy?

The most common situations are: when a targeted therapy stops working and a resistance mutation is suspected; when a first tissue sample was too small for complete molecular testing; and when tracking how well a treatment is working over time by following tumour DNA levels in the blood. Some oncologists also use it to watch for signs of disease returning after surgery, though this remains investigational for most cancer types in India. Your oncologist will tell you whether your specific situation fits one of these recognised indications.

What is a resistance mutation and why does it matter?

When a targeted drug is working, it blocks a specific protein that the cancer needs to grow. Over time, some cancer cells develop a change in the gene that makes that protein — a resistance mutation — which the drug can no longer block, and the cancer starts growing again. Knowing exactly which mutation has appeared matters because different mutations call for different drugs. A liquid biopsy can detect these new mutations in circulating tumour DNA without requiring another invasive procedure. NCCN and ESMO both recognise resistance testing as one of the strongest indications for liquid biopsy.

How does a liquid biopsy tell whether treatment is working?

Cancer cells shed fragments of their DNA into the bloodstream. When treatment is working, the number of cancer cells falls — and so does the amount of tumour DNA detectable in blood. Rising levels may indicate that the disease is not responding or is beginning to progress, sometimes before a change appears on a scan. This monitoring use is more established for some cancers than others, and your oncologist will tell you whether it adds meaningful information in your situation. It is not a substitute for regular imaging.

Is liquid biopsy testing available in India?

Yes. Accredited molecular pathology laboratories in India, including in Hyderabad, offer liquid biopsy panels. Your oncologist will typically recommend a laboratory whose panels cover the specific mutations relevant to your cancer type and treatment history, rather than a broad panel you do not need. CION coordinates molecular testing through accredited partner laboratories. Results usually take one to two weeks, and your oncologist will interpret them alongside your clinical picture and imaging — not in isolation.

How much does liquid biopsy cost?

Cost varies widely depending on which panel is ordered. A test looking for a single known mutation costs considerably less than a broad genomic panel covering many genes. Ask the laboratory for a written quote before proceeding, and check whether your insurer covers molecular diagnostic testing — policies vary significantly. Your oncologist can guide you on which level of testing your situation actually needs, so you are not paying for a panel broader than what the clinical question requires. These costs are indicative and change as the technology evolves.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation